Genetische Vielfalt eines Tumors

Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Article CAS PubMed Google Scholar
Ghoreschi K, Laurence A, O’shea JJ (2009) Selectivity and therapeutic inhibition of kinases: to be or not to be? Nat Immunol 10:356–360
Article CAS PubMed Google Scholar
Hatzivassiliou G, Song K, Yen I et al (2010) RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464:431–435
Article CAS PubMed Google Scholar
Sosman JA, Kim KB, Schuchter L et al (2012) Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 366:707–714
Article CAS PubMed Google Scholar
Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892
Article CAS PubMed Google Scholar

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Universitäts-Hautklinik, Liebermeisterstr. 25, 72076, Tübingen, Deutschland
A.S. Yazdi

Authors

A.S. Yazdi
View author publications
You can also search for this author in PubMed Google Scholar

Correspondence to A.S. Yazdi.

Yazdi, A. Genetische Vielfalt eines Tumors. Hautarzt 63, 587–588 (2012). https://doi.org/10.1007/s00105-012-2412-1

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.